High yield cell-free production of integral membrane proteins without refolding or detergents  by Wuu, Jessica J. & Swartz, James R.
Available online at www.sciencedirect.com
1778 (2008) 1237–1250
www.elsevier.com/locate/bbamemBiochimica et Biophysica ActaHigh yield cell-free production of integral membrane proteins without
refolding or detergents
Jessica J. Wuu a, James R. Swartz a,b,⁎
a Department of Chemical Engineering, Stanford University, Stanford, CA 94305, USA
b Department of Bioengineering, Stanford University, Stanford, CA 94305, USA
Received 15 August 2007; received in revised form 2 January 2008; accepted 28 January 2008
Available online 11 February 2008
Abstract
Integral membrane proteins act as critical cellular components and are important drug targets. However, difficulties in producing membrane
proteins have hampered investigations of structure and function. In vivo production systems are often limited by cell toxicity, and previous in vitro
approaches have required unnatural folding pathways using detergents or lipid solutions. To overcome these limitations, we present an improved
cell-free expression system which produces high yields of integral membrane proteins without the use of detergents or refolding steps. Our cell-
free reaction activates an Escherichia coli-derived cell extract for transcription and translation. Purified E. coli inner membrane vesicles supply
membrane-bound components and the lipid environment required for insertion and folding. Using this system, we demonstrated successful
synthesis of two complex integral membrane transporters, the tetracycline pump (TetA) and mannitol permease (MtlA), in yields of 570±50 μg/
mL and 130±30 μg/mL of vesicle-associated protein, respectively. These yields are up to 400 times typical in vivo concentrations. Insertion and
folding of these proteins are verified by sucrose flotation, protease digestion, and activity assays. Whereas TetA incorporates efficiently into
vesicle membranes with over two-thirds of the synthesized protein being inserted, MtlA yields appear to be limited by insufficient concentrations
of a membrane-associated chaperone.
© 2008 Elsevier B.V. All rights reserved.Keywords: Integral membrane protein; Transporter; Cell-free protein synthesis; In vitro protein synthesis1. Introduction
Integral membrane proteins are a large, diverse class of pro-
teins involved in many critical cellular functions. They include
transporters that regulate movement of materials in and out of
the cell, proteins that mediate cell signaling, and coordinated
complexes involved in energy generation. These critical func-
tions make them popular targets for research and drug devel-
opment, composing 50% of current pharmaceutical targets [1].
However, despite their importance, structural and functional
studies of membrane proteins have been severely limited by
difficulties in producing large quantities of protein. Though
approximately 20–25% of all genes encode membrane proteins⁎ Corresponding author. Department of Chemical Engineering, Stanford Uni-
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doi:10.1016/j.bbamem.2008.01.023[2], only a small fraction (∼150 at publication) have been
successfully crystallized and their structures determined, in part
due to the bottleneck of acquiring milligram quantities of
properly folded protein.
Conventional in vivo expression systems generally produce
only very low yields of integral membrane proteins, typically
0.1 to 15 mg/L [3,4]. This is nearly 1000 times less than cor-
responding yields for overexpressed soluble proteins. The low
in vivo yields seem to result from general cell toxicity attributed
to membrane protein overexpression. One strategy for over-
coming this yield limitation is to express the protein initially as
inclusion bodies, and subsequently (re)fold the protein using
detergents or purified lipid solutions [5,6]. However, the ex-
pression and (re)folding conditions required for this process
often have to be tailored for the particular protein of interest.
Also, these methods do not accurately represent natural folding
pathways, bringing into question whether these techniques will
yield correct structures for the majority of membrane proteins.
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ticularly resistant to in vitro (re)folding strategies [7].
As an alternative approach to overcoming toxicity limita-
tions, we present an improved cell-free protein expression
system for producing membrane proteins. Cell-free expression
performs the same transcription and translation reactions that
occur in the cytoplasm, but eliminates the need to maintain cell
viability. Cell-free expression has additional advantages in that
raw material and energy resources are directed solely to the
production of the single protein product, allowing for more
efficient production. Also, because the reaction is not enclosed
behind a cell wall, we have direct control of the reaction en-
vironment. For example, we can supplement proteins known to
be involved in membrane protein insertion and folding. These
characteristics make cell-free synthesis potentially more ef-
fective as a system for producing high yields of membrane
proteins.
Previous attempts at in vitro synthesis of membrane proteins
have had some success, but have not achieved the yields and
versatility expected from these systems. Results have been
published using cell extracts derived from Escherichia coli [8–
10], wheat germ [11], and rabbit reticulocytes [12,13] as well as
systems using purified components [14,15]. However, unless
the protein is refolded from precipitates or synthesized directly
into detergent or lipid solutions, only 0.1 to 5 μg/mL of folded
protein is obtained [9,14]. Like refolding techniques with in
vivo expressed protein, the use of detergents and purified lipids
does not reflect the natural folding pathway and may not be
effective for the majority of membrane proteins.
In this article, we describe the successful use of a cell-free
expression system supplemented with E. coli-derived vesicles to
produce high yields of folded, active membrane protein without
the use of detergents or refolding steps. This system is based on a
previously reported system developed in the Swartz lab, the
Cytomim system, that mimics the conditions found naturally in
the E. coli cytoplasm [16]. Our system differs from previously
reported in vitro systems used to synthesize membrane proteins
in two important ways. First, the Cytomim system activates
oxidative phosphorylation using vesicle membranes to generate
energy for protein synthesis [17]. The transmembrane proton
gradient generated during oxidative phosphorylation is impor-
tant for insertion of many membrane proteins, in particular those
with charged residues flanking transmembrane regions [18]. Our
system also differs from previous in vitro systems in that it does
not contain the synthetic polymer polyethylene glycol or exo-
genous detergents which may interfere with lipid membranes.
The Cytomim system has been used previously to produce
many complex soluble proteins [19,20]. By supplementing
vesicles derived from the inner membrane of E. coli, we can
augment the available insertion machinery and membrane area
required for folding of integral membrane proteins. Using this
system, we have produced two complex E. coli integral
membrane proteins, the six-transmembrane mannitol permease
and the twelve-transmembrane tetracycline pump, in a folded
and active form without the use of unnatural refolding steps at
yields of 100–500 μg/mL, greater concentrations than any we
have seen reported to date.2. Materials and methods
2.1. Materials
E. coli tRNAs were purchased from Roche Applied Science (Indianapolis,
IN). Dithiothreitol (DTT), Proteinase K, SDS-PAGE gels, and deoxyribonu-
clease (DNase) I were purchased from Invitrogen (Carlsbad, CA). Ultra-Pur®
sucrose used for all gradients was purchased from EMD Chemicals (Gibbstown,
NJ). L-[U-14C]-leucine and 1 mL HiTrap Chelating HP columns were purchased
from GE Healthcare Bio-Sciences (Piscataway, NJ). Chromatography paper was
purchased from Whatman (Kent, UK). [7-3H(N)]-tetracycline was purchased
fromAmerican Radiolabeled Chemicals (St. Louis,MO). Cellulose ester dialysis
tubing, 6–8 kDa and 100 kDa MWCO were purchased from Spectrum La-
boratories (Rancho Dominguez, CA). Microcon YM-30 centrifugal filters were
purchased from Millipore (Billerica, MA). All other reagents were purchased
from Sigma-Aldrich (St. Louis, MO).
2.2. Cell strains and plasmids
S30 extract and inner membrane vesicles were prepared from theE. coliK12-
derived strain KC6 (A19 ΔtonA ΔtnaA ΔspeA ΔendA ΔsdaA ΔsdaB ΔgshA
met+) [21]. The pK7 vector [22] including both a T7 promoter and terminator was
used to construct DNA templates for cell-free protein expression. The tetA gene
encoding the tetracycline pump was cloned from plasmid pEX18Tc [23]. The
mtlA gene encoding mannitol permease was amplified from genomic DNA
using the forward primer 5′-TTCGAACGAAATGTCATCCGATATTAAGATCAAAG-3′ and
reverse primer 5′-GGGGTCTTACTTACGACCTGCCAGCAG-3′. Both tetA and mtlA
genes were inserted into the pK7 vector using SalI and NdeI restriction sites. Ffh
and FtsY, both with C-terminal histidine tags, were purified from BL21 (DE3)
pLysS strains transformed with pET24 Ffh(His) (provided by W. Wintermeyer)
[24] and pET9 FtsY(His) (provided by J. Luirink) [25], respectively.
2.3. Preparation of E. coli inner membrane vesicles
Vesicles were made from KC6 cells, grown according to Zawada, et al. [26],
and purified usingmethods adapted fromOsborn, et al. [27] andMuller and Blobel
[28]. Ten grams of frozen cell pellet were washed three times in 20 mM Tris–HCl
pH 8.0, 1 mM EDTA and resuspended in 10 mL of the same buffer. Lysozyme
(0.2 mg/mL) was added, and the mixture was incubated on ice for 15 min. The cell
solution was then passed through an Avestin EmulsiFlex-C50 homogenizer three
times at 20,000 psi. The resulting cell lysate was centrifuged twice at 30,000 ×g for
20 min each to remove unbroken cells and other particulates. The clarified
supernatant was then ultracentrifuged at 154,000 ×g for 1.5 h to pellet vesicles.
Pellets were resuspended in 5mL of 250 mM sucrose in buffer A (20 mMHEPES-
KOH pH 7.5, 1 mMDTT, and 5mMEDTA) and centrifuged at 231,000 ×g for 1 h.
The final vesicle pellet was resuspended in 5mL of 20% (w/w) sucrose in buffer A.
This crude vesicle solutionwas flash frozen in liquid nitrogen and stored at −80 °C
until use.
Innermembrane vesicles were purified by diluting 0.25mLof the crude vesicle
solution into 1.5mLof 20% (w/w) sucrose in bufferA and loading themixture onto
a sucrose density gradient composed of 2 mL 50% (w/w) sucrose; 3 mL each of
45%, 40%, 35%, and 30% (w/w) sucrose; and 1.5 mL 25% (w/w) sucrose
solutions. All sucrose solutions were made in buffer A. Gradients were spun in a
Beckman L8-80M ultracentrifuge using a SW32.1 Ti rotor for 24 h at 32,000 rpm.
The second and third peaks from the top of the gradient monitored by 280 nm
absorbance correspond to the inner membrane fractions [29]. These fractions were
collected, diluted one to four with buffer B (20 mMHEPES–KOH pH 7.2, 60mM
KCl, and 1 mMDTT), and centrifuged at 231,000 ×g for 2 h. The resulting vesicle
pellet was resuspended in buffer B to a concentration of 1.5–2 mg lipids/mL. This
solution was flash frozen with liquid nitrogen and stored at −80 °C until use.
Typical purified yields were around 15 mg of vesicles (lipid basis) per 10 g of
processed cell paste, corresponding to approximately 10% recovery.
2.4. Cell-free protein synthesis reaction
Protein synthesis was performed as described by Jewett, et al. [22] with a few
modifications. Each reaction was composed of 13.3 μg/mL plasmid template,
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acid, 170 μg/mL E. coli tRNA mixture, 2 mM each of 20 unlabeled amino acids,
0.33 mM nicotinamide adenine dinucleotide, 0.27 mM coenzyme A, 1 mM
putrescine, 1.5 mM spermidine, 4 mM sodium oxalate, 1 mM dithiothreitol,
10 mM ammonium glutamate, 130 mM potassium glutamate, 8 mMmagnesium
glutamate, 10mMpotassium phosphate pH 7.0, 0.1mg/mLT7RNApolymerase,
0.24 volumes of E. coli S30 extract, and 0.41 volumes of purified inner
membrane vesicle solution. T7 RNA polymerase was prepared as described by
Grodberg and Dunn [30]. E. coli S30 extract was prepared from strain KC6,
grown according to Zawada, et al. [26], and prepared according to Jewett, et al.
[31]. 12 μM [14C]-leucine was included in reactions for protein quantification
and visualization by autoradiography. 110 μL and 220 μL reactions were
performed in a thin film format as described byVoloshin, et al. [32] using 12-well
tissue culture plates and incubated for 6 h at 37 °C. No difference in productivity
was observed between the two reaction volumes used in this study.
For reactions in which vesicles were depleted, the vesicle solution was
replaced with deionized water. All the reaction components except T7 RNA
polymerase and plasmid template were assembled in a microfuge tube and
centrifuged for 15 min at 20,000 ×g and 4 °C to remove vesicles included in the
cell extract. The supernatant was transferred to the tissue culture plate. T7 RNA
polymerase and plasmid template were added to initiate protein synthesis, and
the reaction was incubated as described above.
For reactions in which FtsYand Ffh were added, 1 μL of vesicle solution in a
110 μL reaction was replaced with 0.5 μL of solutions containing each purified
protein in 30% (w/v) sucrose (described below). The remaining volume, if any,
was made up with 30% (w/v) sucrose to account for any effects attributed to the
sucrose itself. Control experiments indicate that up to 1 μL of 30% (w/v) sucrose
in a 110 μL reaction does not affect total or inserted protein yields (data not
shown).
Total protein synthesized during the cell-free reaction was quantified by
comparing the amount of protein-incorporated [14C]-leucine versus the overall
[14C]-leucine concentration in the reaction. 4 μL of cell-free reaction product
mixture were aliquoted onto each of two pieces of chromatography paper. One
piece from each pair was washed three times with 5% (w/v) trichloroacetic acid.
Only precipitated protein with the incorporated [14C]-leucine remained on this
paper, while free [14C]-leucine washed away. The second piece was untreated
and contained the full concentration of [14C]-leucine included in the reaction.
After drying, the amount of [14C]-leucine retained on each paper was determined
using a Beckman LS3801 liquid scintillation counter. Background measure-
ments containing no radioactivity were consistently negligible compared to
experimental measurements. The total protein yield was calculated from the
measured scintillation counts using the following equation:
total protein yield μg=mL½  ¼ overall Leu concentration in the reaction mM½ ð Þ
 incorporated ½
14CLeu counts
overall ½14CLeu counts
 
 1
number of leucines per protein
 
MWof protein g=mol½ ð Þ
This equation assumes that radiolabeled and non-radiolabeled leucine are
indistinguishable by the protein synthesis machinery and thus equally likely to
be incorporated at any given leucine residue within each protein.
Prior to any further analysis, all reaction product mixtures were dialyzed in
100 kDa MWCO cellulose ester tubing against 500 volumes of buffer C (10 mM
Tris–chloride pH 8.0, 100mMpotassium chloride) three times for at least 3 h each.
2.5. Sucrose flotation assays
40 μL of dialyzed cell-free reaction product containing 14C-labeled protein
was mixed with 65% (w/w) sucrose and buffer C to a final volume of 0.5 mL and
density of 1.27 g/mL (approximately 51% (w/w) sucrose overall) and loaded on
the bottom of an ultracentrifuge tube. Above this, 2 mL of a premixed solution of
65% (w/w) sucrose and buffer C with density 1.25 g/mL (approximately 45%
(w/w) sucrose overall) was layered. Finally, 1.2 mL of buffer C was layered on
top. For assays containing urea, 40 μL of dialyzed cell-free reaction mixture was
first diluted with 60 μL of 10 M urea and incubated on ice for 30 min. The step
gradient was then assembled using solutions of (a) 47% (w/w) sucrose, 6 M urea(density 1.32 g/mL) and (b) 6 M urea in buffer C. These solutions were mixed to
create the same density profile as described above. The gradients were loaded
into a SW 55 Ti rotor and centrifuged in a Beckman L8-80M ultracentrifuge at
237,000 ×g for 16 h. After centrifugation, the following fraction volumes were
carefully collected by pipette from the top of the gradient: 1 mL, 0.5 mL, five
fractions of 0.4 mL, and one fraction of the remaining solution, if any. The
distribution of radiolabeled protein was determined by liquid scintillation
counting of the collected fractions. The protein yield distribution was
determined by multiplying the relative portion in each fraction by the overall
protein yield of the cell-free reaction. Vesicle distribution was determined by
lipid assay (described below).
2.6. Proteinase K digestion
Proteinase K and 10 mM calcium chloride were added to dialyzed cell-free
product mixtures containing 14C-labeled protein and incubated for 0 to 60 min
(see figure legends for concentrations and incubation temperatures). Reactions
performed in the presence of detergent contained 2% lithium dodecyl sulfate
(LDS). Digestion reactions were quenched with 6.25 mM phenylmethylsulfonic
acid (PMSF) and loaded immediately onto SDS-PAGE gels. Gels were dried on
chromatography paper and sandwiched with Biomax MR film (Kodak,
Rochester, NY) for four days. Films were developed using a Konica Medical
Film Processor QX-70.
2.7. TetA activity assay
Dialyzed cell-free product mixtures containing unlabeled TetA were
incubated with 13.3 mM NADH for 1 min at 37 °C. Where indicated, 1 mM
DTT was also included in the assay mixture. 10 μM [3H]-tetracycline and
0.5 mM cobalt chloride were then added, and the reaction was further incubated
for the indicated times. After incubation, the reactions were filtered through a
Microcon YM-30 centrifugal filter and washed with ice cold buffer C. The filters
were then removed and counted on a liquid scintillation counter to determine the
amount of retained 3H-labeled tetracycline.
2.8. Ffh and FtsY purification
BL21 (DE3) pLysS strains harboring either pET24 Ffh(His) or pET9 FtsY
(His) were grown in 1 L cultures using LB media. Cultures were induced with
1 mM IPTG at OD(600 nm) 0.6 and harvested 3 h after induction. Cell pellets
were resuspended in 20 mL buffer D (50 mM sodium phosphate pH 8.0, 5 mM
Tris–chloride, 700 mM NaCl, and 10 mM 2-mercaptoethanol) containing 1 mM
PMSF and 1/1000 volumes protease inhibitor cocktail (Sigma P8849). The cells
were lysed using an Avestin EmulsiFlex-C50 homogenizer at 20,000 psi and
centrifuged twice at 30,000 ×g for 30 min each. DNase I (75 units/mL) was
added to the resulting supernatants, and the mixture was incubated for 1.5 h at
room temperature.
His-tagged protein was purified using 1 mLHiTrap chelating HP columns pre-
bound with 0.1 M nickel sulfate. The columns were equilibrated with five column
volumes of buffer D. Each cell lysate was diluted to 30 mL with buffer D and
loaded onto separate columns. Columns were washed with ten column volumes of
buffer D containing 20 mM imidazole, then eluted with three column volumes of
buffer D containing 50mM imidazole followed by six column volumes of buffer D
containing 250 mM imidazole, collected in 1 mL fractions. Ffh(His) eluted in the
second through fourth fraction with 250 mM imidazole. FtsY(His) eluted with
50 mM imidazole as well as in the first fraction with 250 mM imidazole. Fractions
containing each respective eluted protein were pooled and dialyzed three times for
1 h each in buffer D using 6–8 kDa MWCO dialysis tubing. After dialysis, the
collected pools were diluted two-fold with 60% (w/v) sucrose, yielding an overall
concentration of 30% (w/v) sucrose. The final solutions were flash frozen with
liquid nitrogen and stored at −80 °C until use. Concentrations were estimated by
comparison with BSA standards on an SDS-PAGE gel.
2.9. Lipid assay
Lipids were separated from water-soluble phosphate using the extraction
method of Bligh and Dyer [33]. The aqueous solution containing lipids was
Table 1
Protein yields from cell-free reaction
Protein a Total yield b
(μg/mL)
Inserted yield
(μg/mL)
% Insertion
TetA Vesicles supplemented 850±30 570±50 66±4
Vesicles depleted 610±20 5±2 0.8±0.4
MtlA Vesicles supplemented 330±50 130±30 38±4
Vesicles depleted 180±30 28±8 16±5
a TetA and MtlA results represent the average of three and five experiments,
respectively.
b Total yield includes all protein synthesized in the cell-free reaction, both
vesicle-associated and non-associated proteins.
Fig. 1. SDS-PAGE analysis of (a) cell-free reaction product mixture and
(b) purified vesicles containing synthesized TetA: coomassie stained (Lanes 1
and 3) and viewed by autoradiography (Lanes 2 and 4). 10 μL of cell-free
reaction mixture or 14 μL of recovered sucrose gradient fraction was loaded per
lane, respectively. The cell-free mixture contains approximately 10 mg/mL of
protein in addition to the synthesized protein which appears only in the
coomassie stained image. Similarly, the E. coli-derived vesicles also contain
native membrane proteins that only appear in the coomassie stained image.
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thanol) ratio. To this, 1.25 parts chloroform followed by 1.25 parts water were
added and mixed. After phase separation, the lipids were collected in the denser
chloroform fraction. The chloroform was evaporated using a CentriVap cen-
trifugal concentrator (Labconco, Kansas City, MO), leaving a dried lipid film.
The extracted lipids were then quantified by phosphorus assay [34].
3. Results
3.1. Cell-free expression of the tetracycline pump, TetA
The Cytomim cell-free expression system contains an E. coli
cell extract which provides ribosomes and other enzymatic
machinery needed for protein expression and folding. To this,
nucleotides, amino acids, salts, and small molecule cofactors are
added. Protein synthesis is initiated by addition of T7 RNA
polymerase and a DNA plasmid template encoding the desired
target gene behind a T7 promoter. For membrane protein ex-
pression, the reaction is supplemented with 0.7–0.8 mg/mL
(lipid basis) of purified E. coli inner membrane vesicles.
Combined with the vesicles already present in the cell extract,
this provides an overall vesicle concentration of about 1 mg/mL
(lipid basis).
Using this cell-free system, we expressed the tetracycline
pump TetA (class C) derived from pBR322. TetA is a complex
integral membrane protein, with a molecular weight of 41 kDa
and twelve-transmembrane segments. It is a member of the
major facilitator superfamily (MFS) of sugar and drug tran-
sporters, examples of which are found in bacterial up to mam-
malian organisms [35]. TetA is expressed very well in our
system with total yields of 850±30 μg produced per milliliter of
cell-free reaction (Table 1), as determined by 14C-leucine in-
corporation and viewed by SDS-PAGE (Fig. 1). This high yield
depends on the presence of inner membrane vesicles in the
reaction. Vesicles can be depleted to less than 0.08 mg/mL (lipid
basis) by replacing the purified vesicle volume with water and
centrifuging the reaction prior to protein synthesis to remove
vesicles included in the cell extract. If vesicles are depleted, the
total protein yield decreases by 30%, likely reflecting the de-
pendence of the Cytomim system on oxidative phosphorylation
for energy generation [17].
The total protein yield, however, includes both TetA that is
properly inserted in membrane vesicles as well as any pre-
cipitated or misfolded TetA. To determine what fraction of the
produced TetA is vesicle-associated, we separated the vesiclesfrom unincorporated protein using a sucrose flotation assay.
The sample is loaded in the bottom layer of a three-step suc-
rose gradient with densities chosen such that vesicles (1.12–
1.24 mg/mL) float to the interface between the top and middle
layers while the denser precipitated protein remains in the
bottom layer (Fig. 2a). In typical experiments, greater than 85%
of the included vesicles float to the expected location and are
collected in the second and third fractions as determined by lipid
assay (data not shown).
Fig. 2b shows the distribution of expressed TetA after sucrose
flotation.WhenTetA is produced in a cell-free reaction containing
inner membrane vesicles, over 80% of the synthesized membrane
protein is recovered in the vesicle-containing fractions of the
sucrose gradient. In contrast, if vesicles are depleted from the cell-
free reactionmixture prior to protein synthesis, nearly all (99%) of
the TetA remains at the bottom of the gradient, consistent with the
expected location of unincorporated protein. Thus, it appears that
themajority of TetA synthesized in vesicle-containing reactions is
membrane-associated.
To eliminate the possibility that the TetA is non-specifically
associated with the vesicles, the flotation assay was repeated after
incubating the sample with urea for 30min and with the inclusion
of 6 M urea throughout the gradient. Urea acts as a chaotrope and
disrupts non-specific hydrophobic interactions between unin-
corporated protein and vesicle membranes. Properly inserted
protein, however, remains predominantly membrane-integrated
on the timescales of the ultracentrifugation. We should note that
Fig. 3. (a) Autoradiogram of synthesized TetA after exposure to Proteinase K.
For each sample, 10 μL of dialyzed cell-free reaction product mixture was
incubated at 25 °C with 0.2 mg/mL Proteinase K with or without the addition of
2% LDS detergent. After incubation, the resulting fragments were separated by
SDS-PAGE. TetA was synthesized with 14C-leucine for visualization by auto-
radiography. The expected position for full-length TetA is indicated. The last
lane shows the molecular weight markers visualized by coomassie staining of
the same gel. Abbreviations: Proteinase K (Prot K), lithium dodecyl sulfate
(LDS). (b) Topology of properly folded TetA (396 amino acids) as described by
Lewis, et al. [60]. Cytoplasmic loops are denoted ‘C’ and their sizes in amino
acids (aa) are indicated. Transmembrane segments are denoted ‘TM’.
Fig. 2. (a) Schematic of sucrose flotation assay used to separate vesicle-associated
protein from unincorporated protein. Dialyzed cell-free reaction mixtures are
mixed with a high density sucrose solution and loaded on the bottom of an
ultracentrifuge tube (overall density 1.27 mg/mL). Above this are two less dense
layers of sucrose solution (densities 1.25 and 1mg/mL).During ultracentrifugation,
the vesicles float to their equilibrium position where they are easily separated from
unincorporated protein remaining at the bottom of the tube. (b) Distribution of
synthesized 14C-labeled TetA after sucrose flotation.
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misfolded protein. Since solubilized proteins are small and ex-
perience high drag force, they, like the large precipitates, remain
at the bottom of the gradient during ultracentrifugation. Thus,
only proteins that are fully integrated into the vesicle membrane
float in the urea-containing gradient. As shown in Fig. 2b, even
in the presence of 6 M urea, 66% of the synthesized TetA re-
mains vesicle-associated. The stably integrated TetA corresponds
to 570±50 μg of vesicle-associated protein synthesized per mil-
liliter of cell-free reaction, approximately four hundred times
typical in vivo TetA concentrations (1–1.5 μg/mL) [36].3.2. Assessing TetA folding and activity
To further verify that the protein is integrated in vesicle mem-
branes, we subjected the synthesized TetA to protease digestion.
Proteinase K is a non-specific protease that preferentially de-
grades accessible polypeptide. Portions of the synthesized protein
protected by the lipid membrane will be degraded significantly
more slowly by the protease. Thus, by monitoring degradation of
the synthesized TetA, we can assess whether the protein is in-
serted into vesicle membranes or is loosely associated on the
vesicle surface.
Fig. 3a shows the protein fragments obtained upon digestion
by Proteinase K as viewed by SDS-PAGE and autoradiography.
Only the target protein is produced during the cell-free reaction
and contains radiolabeled leucine; therefore, all bands visua-
lized on the autoradiogram are attributed to the target protein
and its digestion products. Before exposure to the protease, the
dominant protein band corresponds to full-length TetA. Like
many other membrane proteins, 41 kDa TetA runs slightly faster
than its predicted molecular weight on SDS-PAGE, appearing
near 35 kDa [36]. After exposure to Proteinase K, we see
protection of full-length TetA even at 1 h of incubation. When
lithium dodecyl sulfate (LDS) detergent is added to dissolve
vesicle membranes, this protection is abolished, with full-length
TetA disappearing after 15 min of exposure. The membrane-
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protein that is incorporated into vesicles and not just loosely
associated on the membrane surface.
Protection of full-length TetA, however, does not preclude
the possibility that the protein is misfolded since strongly ag-
gregated protein may also be inaccessible to proteases in the
absence of detergents. To address this possibility, we note that, in
addition to full-length TetA, many distinct smaller bands appear
during the course of the incubation and are protected from
digestion in a membrane-dependent manner. Many of these
smaller bands correspond well with fragments that would resultFig. 4. (a) Schematic of TetA activity assay. Dialyzed cell-free reactions containing sy
at 37 °C to initiate proton pumping across vesicle membranes. 10 μM 3H-labeled
provides the driving force for transport of tetracycline into the vesicle by TetA. Afte
filtration, and vesicle-associated tetracycline is quantified. (b) Tetracycline accumula
times and the addition of the reducing agent, DTT, are indicated. The dotted line indicfrom degradation of the larger cytoplasmic loops in properly
folded TetA (Fig. 3b). In our synthesis reactions, we expect that
an inverted vesicle orientation –with the cytoplasmic side of the
membrane facing outwards – would be required in order for the
insertion machinery to accept newly translated polypeptide from
outside the vesicle. Thus, these cytoplasmic loops would be
exposed to the protease. For example, the persistent band near
18 kDa corresponds well with fragments formed by degrada-
tion of the third cytoplasmic loop (C3) of TetA located between
transmembrane (TM) segments six and seven, producing frag-
ments TM 1–6 (17.7 kDa) and TM 7–12 (18.5 kDa). Thenthesized TetA or CAT (control) were incubated with 13.3 mMNADH for 1 min
tetracycline and 0.5 mM cobalt chloride were then added. The proton gradient
r incubation at 37 °C, the vesicles are isolated from the surrounding solution by
tion in vesicles containing synthesized TetA versus control vesicles. Incubation
ates the tetracycline concentration (10 μM) present on the exterior of the vesicles.
Fig. 5. SDS-PAGE analysis of cell-free reaction product mixture containing
synthesized MtlA: coomassie stained (Lane 1) and viewed by autoradiography
(Lane 2). 13 μL of cell-free reaction was loaded per lane. The cell-free mixture
contains approximately 10 mg/mL of protein in addition to the synthesized
protein which appears only in the coomassie stained image.
Fig. 6. Distribution of synthesized 14C-labeled MtlA after sucrose flotation
(a) without urea and (b) with 6 M urea throughout the gradient.
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(producing fragments TM 1–4, 11.8 kDa) or from digestion of
loops C3 and C5 (producing fragments TM 7–10, 11.8 kDa).
Similar assignments can be proposed for the bands near 29 kDa
(fragments TM 1–10, 33.4 kDa), 25 kDa (fragments TM 5–12,
26.4 kDa), 5 kDa (fragments TM 11–12, 5.1 kDa), and 4 kDa
(fragments TM 5–6, 4.1 kDa). The appearance and persistent
protection of distinct protein fragments suggests that the syn-
thesized TetA forms a well-defined and consistent structure in-
volving the vesicle membrane and is not randomly misfolded as
aggregates or assembled intomembrane-independent precipitates.
In addition to the protease protection assays, we also assessed
the activity of the synthesized protein to verify folding of TetA.
TetA functions as an antiporter in the E. coli inner membrane,
transporting a metal–tetracycline complex out of the cytoplasm
concurrently withmovement of a proton from the periplasm. The
transmembrane proton gradient generated by the electron
transport chain provides the driving force for this process. To
test for activity of the synthesized TetA, we took advantage of
the fact that the vesicles in our reaction are derived from E. coli
inner membranes (Fig. 4a). These natural membranes contain the
proteins and electron carriers of the electron transport chain.
Upon addition of NADH to the vesicle exterior, the electron
transport chain generates a proton gradient across the vesicle
membrane which can then be used to drive transport of tetra-
cycline, as a complex of tetracycline plus a divalent metal cation,
into the vesicle interior. The vesicles are then separated from the
surrounding solution by filtration. The amount of tetracycline
that is pumped into the vesicle is quantified using radiolabeled
tetracycline.
Fig. 4b shows the amount of tetracycline retained inside
vesicles containing the synthesized TetA as compared to control
vesicles from a reaction in which an unrelated protein, chlo-
ramphenicol acetyl transferase (CAT), was expressed. Expe-
riments were performed varying the duration of tetracycline
pumping as well as modulating the presence of dithiothreitol
(DTT) to mimic the reduced environment on the cytoplasmic side
of the membrane. In all the experiments with control vesicles,some tetracycline is retained, most likely due to diffusion of
tetracycline across the vesicle membranes. Tetracycline is a
weakly lipophilicmolecule and is believed to enter living cells via
passive diffusion through the lipid membrane [37]. Estimating a
vesicle diameter of 100 nm as determined by dynamic light
scattering (data not shown), the quantity of retained tetracycline in
the control vesicles is comparable to the external tetracycline
concentration (10 μM), consistent with a diffusion-driven
process. In contrast, when the assays are performed with vesicles
containing synthesized TetA, additional tetracycline is retained
under all the conditions tested. Some variability is observed in the
amount of captured tetracycline which we believe, rather than
resulting from changes in the reaction conditions, is due to
Fig. 7. (a) Topology of MtlA (637 amino acids). The large C-terminal domain
and cytoplasmic loops are indicated. (b) Autoradiogram of synthesized MtlA
after exposure to Proteinase K. For each sample, 13 μL of dialyzed cell-free
reaction product mixture was incubated at 37 °C for the times indicated with
0.2 mg/mL Proteinase K with or without the addition of 2% LDS detergent.
After incubation, the resulting fragments were separated by SDS-PAGE. MtlA
was synthesized with 14C-leucine for visualization by autoradiography. The
expected positions for full-length MtlA, the 6-transmembrane fragment, and the
4-transmembrane fragment are indicated. The first lane shows the molecular
weight markers visualized by coomassie staining of the same gel. Abbreviations:
Proteinase K (Prot K), lithium dodecyl sulfate (LDS).
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and background binding to the filter and vesicle membranes.
Further assay development is needed to reduce this variability.
Nevertheless, the increased tetracycline accumulation – approxi-
mately two to three times above background – is similar to
previous reports using vesicles containing in vivo produced TetA
(class C) [38]. A quantitative comparison of specific activity is
difficult due to differences in expression level and assay con-
ditions, in particular the pH environments surrounding the vesicle
membrane. However, the consistent increase in tetracycline
accumulation in the TetA-containing vesicles suggests that the
cell-free synthesized TetA has pumping activity.
3.3. Cell-free expression of mannitol permease, MltA
Using the same cell-free expression system, we also ex-
pressed mannitol permease (MtlA), a 68 kDa protein containing
six-transmembrane segments. MtlA is part of the phospho-
transferase system (PTS) and catalyzes the phosphoenolpyr-
uvate-dependent transport of mannitol into the cytoplasm of
E. coli. MtlA is an interesting model protein for our system
because its insertion mechanism has been well characterized
and is known to involve many different components, including
the signal recognition particle (SRP), the SRP receptor protein
FtsY, the Sec translocon, and an integral membrane chaperone
YidC [39–41]. Thus, successful expression of MtlA would
indicate that our system includes and activates these complex
insertion and folding pathways, despite the number of factors
involved.
MtlA is expressed well in our cell-free system with total
yields of 330±50 μg total MtlA produced per milliliter of cell-
free reaction when vesicles are included (Table 1 and Fig. 5). As
in the case with TetA, this total includes both vesicle-associated
and unincorporated protein. The sucrose flotation assay was
used to quantify the vesicle-associated protein. Normally, un-
incorporated membrane protein forms precipitates which are
much denser than vesicles. However, in the case of MtlA, we
found that both the vesicle-depleted reactions as well as re-
actions supplemented with vesicles resulted in a majority of the
synthesized MtlA being recovered in the lighter sucrose frac-
tions (Fig. 6a). Since MtlA flotation occurs even when very
few vesicles are present, it appears that unincorporated
MtlA forms large collections of protein that are less tightly
packed than conventional precipitates, perhaps stabilized by
MtlA's large soluble C-terminal domain and possibly containing
large amounts of entrapped water. Evidence for such defined
structures was observed by dynamic light scattering indicating
that uniform structures of 0.5–1 μm in size were formed in the
reactions depleted of membrane vesicles (data not shown).
This anomalous behavior disappears, however, when the flo-
tation assay is repeated with the inclusion of 6M urea (Fig. 6b). In
addition to disrupting non-specific hydrophobic interactions with
vesicle membranes, the high urea concentration likely also solu-
bilizes the large structures of unincorporated protein, yielding
smaller entities that do not migrate significantly through the
gradient due to high drag force. Properly incorporated MtlA,
however, mostly remains embedded in the vesicle membranedespite this harsh treatment. The gradients containing urea in-
dicate that 38% of the protein is recovered in the vesicle-
containing fractions when MtlA is expressed in the presence of
inner membrane vesicles. In contrast, when vesicles are depleted
prior to protein synthesis, MtlA remains predominantly in the
fractions at the bottom of the gradient, consistent with unin-
corporated protein. The small fraction of MtlA that floats in the
vesicle-depleted reactions,we believe, representsMtlAmolecules
that have incorporated into the residual vesicles remaining after
vesicle depletion. The calculated surface concentration ofMtlA in
these vesicles is consistent with that found in reactions with
augmented vesicle concentrations. The sucrose flotation assay
indicates that our cell-free system with supplemented vesicles
produces 130±30 μg/mL of vesicle-associated MtlA, over sixty
times typical in vivo MtlA concentrations (b2 μg/mL) [42,43].
3.4. Assessing MtlA folding
To determine if the synthesized MtlA is properly folded in
the vesicle membranes, we subjected the protein to protease
digestion. Significant insight can be gained as to the structure of
the synthesized MtlA because of its convenient topology. Pro-
perly folded MtlA contains a six-transmembrane N-terminal
portion connected to a large, cytoplasmic C-terminal domain
(Fig. 7a) [44]. As indicated by the TetA digestion pattern, the
Table 2
Comparison of concentrations in cells vs. cell-free reaction
Ribosomes
(μM)
SRP
(nM)
FtsY
(μM)
Membrane
area (m2/mL)
Cellular concentrations 42 [49] 80 a 18 a 7.3 b
Cell-free reaction concentrations
(standard reaction)
2 [48] 4 c 0.8 c 0.16 d
Cell-free reaction concentrations
(with supplementation)
2 [48] Up to
60
Up to
1.7
0.16 d
a Calculated from values from Drew [2] and assuming 0.88 μm3 volume per
cell [49].
b Calculated from values from Neidhardt [49]: 6.4 μm2 membrane area per
cell, 0.88 μm3 volume per cell.
c Estimated from relative ribosome concentrations.
d Includes supplemented inner membrane vesicles.
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inverted orientation with the cytoplasmic side facing outwards.
Thus, the cytoplasmic domains of MtlA should similarly be
exposed on the exterior of our vesicles. When vesicles con-
taining properly folded MtlA are exposed to Proteinase K, the
large C-terminal domain is easily accessed by the protease and
quickly degraded, leaving a 35 kDa fragment corresponding to
the remaining six-transmembrane region. This characteristic
fragment is often used in MtlA studies as an indicator of
insertion and folding [40,45]. Likewise, large cytoplasmic loops
are more quickly degraded by the protease compared to trans-
membrane segments or periplasmic loops which are protected
by the lipid membrane. MtlA contains a large cytoplasmic loop
of approximately 89 amino acids between the fourth and fifth
transmembrane segments [44]. Digestion of this loop results in a
characteristic 17 kDa fragment corresponding to the remaining
N-terminal four-transmembrane segment.
Fig. 7b shows the protein fragments obtained for cell-free
synthesized MtlA after exposure to Proteinase K. Before ex-
posure to the protease, the dominant protein band corresponds
to full-length MtlA (68 kDa). Characteristic of MtlA, this band
runs slightly faster than its predicted molecular weight on SDS-
PAGE, appearing near 60 kDa [45]. After exposure to
Proteinase K, the full-length MtlA band disappears in favor of
smaller bands. Digestion is very rapid and occurs even before
the “zero” timepoint can be quenched. Two large fragments at
30 kDa and 16 kDa, however, appear and persist even after a
one hour incubation. The 30 kDa band appears first and cor-
relates well with the expected position of the characteristic
35 kDa fragment corresponding to the six-transmembrane
segment. This is consistent with the location of this fragment
identified in previous reports [45]. Over time, this fragment
diminishes in favor of a 16 kDa band, which is consistent with
the expected 17 kDa fragment corresponding to the four-
transmembrane segment.
This digestion experiment is performed using the total cell-
free reaction sample containing both vesicle-associated and
unincorporated MtlA. It is interesting that, though the sucrose
flotation results with urea indicate that a majority of the syn-
thesized protein is in the unincorporated form, we do not see
protease protection of full-length MtlA protein, even at the
earliest timepoints, as might be expected for conventional ag-
gregates. Instead, this protein is degraded rapidly, initially
accumulating as 30–35 kDa fragments and disappearing within
the first 5 min of incubation. The accessibility of unincorporated
MtlA to Proteinase K digestion is consistent with other reports
for MtlA [14,46] and supports the hypothesis that, in the
absence of a denaturant like urea, unincorporated MtlA forms
loosely-packed structures, as opposed to typical densely packed
aggregates.
When the protease digestion experiment is repeated in the
presence of LDS detergent, the lipid membranes are dissolved,
allowing access to the periplasmic loops and transmem-
brane segments. Under these conditions, neither the character-
istic 30 kDa fragment nor the 16 kDa fragment remains after
15 min of incubation. Membrane-dependent protection of the
expected protein fragments indicates that the synthesized MtlAis inserted and has the expected structure within the vesicle
membranes.
3.5. Factors that limit MtlA synthesis
Both MtlA and TetA are native bacterial transporters. How-
ever, there appear to be limitations in the pathways recreated in
our cell-free system that apply only to MtlA synthesis and not to
TetA. Though MtlA has fewer transmembrane segments and the
overall protein production rate is lower, only 38% of the syn-
thesized MtlA is inserted into the vesicle membranes compared
with over 66% of synthesized TetA.
In E. coli, the insertion pathway used by most membrane
proteins is well-studied, involving a combination of soluble and
membrane-bound chaperones [47]. As the first few amino acids
of the membrane protein emerge from the ribosome, they are
recognized and bound by the signal recognition particle (SRP).
Interactions between SRP and its membrane-associated recep-
tor, FtsY, facilitate docking of the peptide–ribosome complex to
the lipid membrane. Upon docking, SRP and FtsY are released
and the N-terminal end of the peptide is transferred to the Sec
translocon, a channel embedded in the lipid membrane through
which the translated peptide is extruded. Via interactions that
are not fully understood, the inserted transmembrane segments
are released into the lipid environment, often with the aid of a
membrane-bound chaperone, YidC. In addition to the chaper-
ones that aid insertion, many membrane proteins also require
the electrostatic potential created by the transmembrane proton
gradient to aid in locating charged residues that flank the
transmembrane regions.
The insertion and folding pathway for MtlA has been well
characterized. It is known to require SRP, FtsY, the Sec
translocon, and YidC [39–41]. MtlA insertion does not depend
on SecA, SecB, or the presence of a transmembrane proton
gradient [39,46]. Both SRP and FtsYare provided to the cell-free
reaction in the cell extract which supplies most of the enzymatic
machinery used for protein synthesis. FtsY is evenly distributed
between soluble and membrane-associated forms [47]; thus, we
regard it as a soluble component. The Sec translocon and YidC
are integral membrane proteins included in the inner membrane
vesicles that are added to the reaction. Thus, to identify the
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and FtsY, as well as the membrane-bound components.
Initially, the soluble components, SRP and FtsY, appeared to
be likely candidates limiting MtlA insertion. Enzymes supplied
in the cell extract are known to exist in the Cytomim reaction
at approximately one-twentieth their cellular concentrations
[48]. This dilution could be particularly restricting for SRP
which is only present at about 40 copies per cell [2], yielding a
concentration of roughly 4 nM to accommodate the 2 μM of
ribosomes found in the cell-free reaction [48]. Insufficient
concentrations of SRP or FtsY would ultimately limit the ability
of free, translating ribosomes to dock to unoccupied translo-
cons. To test this limitation, histidine-tagged versions of Ffh, the
protein component of SRP, and FtsY were purified and
supplemented in the cell-free reaction (Table 2). The 4.5S
RNA component of SRP has previously been shown to be
present in the E. coli tRNA mixture that is added to the reaction
[14]. Upon incubation, the 4.5S RNA recombines with Ffh to
form active SRP molecules. Supplementation of Ffh, FtsY, or
both proteins showed only small increases (less than 5%), if any,
in inserted MtlA yields. This result was observed with sup-
plemented concentrations ranging between 30–60 nM Ffh and
1.0 – 1.7 μM FtsY (data not shown). Thus, docking of the
ribosomes to available translocons does not appear to limit
MtlA synthesis.
Given that SRP and FtsY availability does not appear to be
limiting, we next addressed whether the translocon and YidC
concentrations are sufficient to accommodate the produced
protein. The availability of free translocons is determined both
by the volumetric concentration of vesicles present as well as
the surface concentration of translocons in each vesicle. For this
study, we assessed how inserted MtlAyield varies with changes
in the vesicle concentration included in the reaction. Fig. 8
shows that, as the vesicle concentration decreases, we see a
steady decrease in the percentage of synthesized MtlA that is
inserted into vesicles. This trend is observed even at the highest
vesicle concentrations tested, suggesting that the limitation in
MtlA insertion is membrane-related. The dependence on vesicleFig. 8. Effect of vesicle concentration on the yield of vesicle-associated MtlA.concentration may reflect a limitation in the insertion rate, the
rate of release from the translocon to the lipid environment, or
an intrinsic limit to the density of protein that can be accom-
modated in the lipid bilayer. Further studies varying translocon
and YidC surface concentrations are needed, however, to fully
elucidate the membrane-mediated insertion limitation.
4. Discussion
Cell-free expression systems have been used to synthesize a
diverse range of complex soluble proteins. We demonstrate that
these systems can also be used to produce integral membrane
proteins with high yields. The system we describe is based on
the previously reported Cytomim expression system supple-
mented with vesicles derived from E. coli inner membranes.
Using this system, we have produced two E. coli transporters,
MtlA and TetA, at concentrations sixty and four hundred times
those typical for in vivo production, respectively. SDS-PAGE
analysis of vesicles purified following the cell-free reaction
(Fig. 1b, lane 3) indicates that the produced membrane protein is
the dominant protein in the vesicle membranes. We can estimate
the fraction of surface area on the vesicle that is occupied by the
target membrane protein from the inserted protein yields. The
surface coverage is calculated based on the assumptions that the
E. coli inner membrane is roughly 50% lipid and 50% protein
by surface area and that a typical membrane protein covers the
same area as 70 lipids, i.e. 35 per leaflet [49]. Based on these
calculations, the reported yields correspond to approximately
10% surface coverage by MtlA and 40% surface coverage by
TetA. Generally, in vivo expression produces up to 10%–15%
surface coverage by the overexpressed membrane protein in the
best cases [3]. Thus, in addition to higher overall concentra-
tions, the cell-free approach is also able to attain higher surface
concentrations, which may be advantageous when purifying the
expressed protein or for functional studies of the protein within
the natural membrane environment. The values reported here
also potentially underestimate actual yields because (1) we do
not recover all of the vesicles at the top interface of the sucrose
flotation gradients (approximately 85% by lipid content) and (2)
the harsh 6 M urea treatment does slowly extract even properly
inserted protein (time constant ∼66 h, data not shown).
Themethod presented in thiswork describes higher volumetric
concentrations of protein achieved compared to conventional in
vivo methods. However, since many of the components in the
cell-free reaction – most notably the cell extract and purified
vesicles – are derived from bacterial sources, it is also interesting
to compare the yields per culture volume, which is perhaps a
better measure of the amount of protein achieved per resource or
labor cost. In the case of cell extract, a typical 8 L fermentation
reaching 30 OD (prepared according to Zawada, et al. [26] and
Jewett, et al. [31]) yields enough extract to perform 2.5 L of cell-
free reactions. Thus, the volumetric yields achieved in vesicle-
supplemented cell-free reactions correspond to 180 μg of TetA
and 40 μg of MtlA produced per milliliter of culture volume,
equivalent to 125 and 20 times typical in vivo yields, respectively.
In terms of the vesicle preparation (as described in Material and
methods), a typical 8 L fermentation supplies vesicles for 750 mL
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MtlA yields to 35 and 6 times typical in vivo production levels,
respectively. The described vesicle preparation protocol, how-
ever, only produces roughly 10% of the theoretical vesicle yield
from the processed cell mass. Further optimization of the vesicle
preparation procedure may help improve the overall vesicle yield
and, in turn, the amount of membrane protein produced per cell
culture volume.
The improved membrane protein yields relative to in vivo
systems are most likely a direct result of decoupling cell viability
and reproduction requirements from protein expression. Several
theories have been proposed as to why overexpression of
membrane proteins is toxic to living cells. One hypothesis is that
membrane protein overexpression inhibits the cell's ability to
produce other membrane-bound and secreted proteins essential
for cell viability, for example those involved in energy gene-
ration and nutrient uptake. This may result from overexpressed
aggregates interfering with folding of critical membrane proteins
or from a shortage of sufficient insertion machinery to ac-
commodate both the overexpressed and critical proteins, since
insertion components exist at concentrations 20 to 500 times less
than ribosome concentrations [2]. Because our cell-free system
does not require new synthesis of these unrelated membrane
proteins, this limitation on membrane protein overexpression is
alleviated.
Another proposed theory is that overexpressed membrane
proteins crowd the cellular membranes, which may be detri-
mental to cell viability. This hypothesis is based on the iden-
tification of cell strains that are more tolerant to membrane
protein overexpression apparently due to mutations promoting
higher lipid production [50,51]. However, the limitation in
protein content within the cell envelope does not appear to be
caused by an intrinsic defect in the integrity or fluidity of the
lipid bilayer. Earlier reports have shown that, when lipid syn-
thesis is impeded, E. coli cell membranes can accumulate up to
84% surface coverage by membrane proteins [52], far beyond
the typical 50% surface coverage normally present in E. coli
inner membranes. Interestingly, after lipid production is rein-
stated, cell growth and synthesis of DNA, RNA, and protein do
not resume until normal membrane compositions are re-
established [52]. Thus, cell viability evidently places additional
requirements on membrane composition beyond the spatial
limitations within the membrane itself. However, since our cell-
free approach does not depend on cell growth to accumulate
expressed protein, we are not constrained by these additional
limitations in membrane protein surface coverage.
We should note that comparable or even higher yields for
some membrane proteins have been achieved by other in vitro
[8] and even a few in vivo [6] expression systems. However, to
the best of our knowledge, this has only been accomplished
with the aid of refolding techniques or, in the case of in vitro
synthesis, by synthesis into detergents or lipids [8]. Although
these approaches have been used with considerable success,
there are potential limitations to detergent- or lipid-based (re)
folding strategies. Results often vary from protein to protein,
with re-optimization of detergent composition, concentration,
and incubation conditions being common. This practical limi-tation can sometimes be mitigated by (re)folding from cell-free
produced precipitates or by synthesizing directly into deter-
gents and/or lipids, both of which have proven to be more
generalizable approaches requiring less screening of detergents
[53]. More concerning, however, is that these approaches differ
significantly from natural folding pathways, primarily relying
on thermodynamic driving forces without the aid of membrane
protein chaperones to achieve the correct folded structure.
Detergent- and lipid-based strategies are designed to randomly
seek a structure corresponding to the global energetic mini-
mum. Natural folding pathways, on the other hand, utilize co-
translational constraints introduced by chaperones and may
instead result in structures that are kinetically trapped at a local
energetic minimum. This notion is supported by the fact that
many α-helical membrane proteins are unstable in deter-
gent micelles [5]. Thus, though these approaches have been
used successfully for some proteins, (re)folding strategies for
α-helical membrane proteins may not be broadly applicable.
In contrast, the cell-free expression system presented in this
article does not require detergents or refolding steps, presumably
using the natural pathway for membrane protein insertion and
folding. Soluble chaperones, like SRP and FtsY, are contained in
the cell extract. Membrane-bound chaperones, notably the Sec
translocon and YidC, are supplied in the E. coli inner membrane
vesicles. Successful synthesis of MtlA suggests that these
chaperones and pathways are indeed present and active in our
system, since MtlA synthesis is known to require these four
components [39–41]. Consistent with this, when E. coli vesicles
were replaced with synthetic liposomes lacking translocons or
other membrane-bound components, integrated MtlA was not
observed (data not shown). Less is known about the folding
pathway for TetA. Lewis, et al. [54] demonstrated that several
substitutions replacing neutral residues with charged residues
could be made in the inter-membrane regions of TetA without
inhibiting insertion of the transmembrane segments. It is un-
likely that the protein could overcome the kinetic barriers for
transporting additional charges across the hydrophobic bilayer if
the protein was inserted by spontaneous insertion. Thus, TetA
most likely utilizes a membrane-bound chaperone like the Sec
translocon. The large number of transmembrane segments in
TetA also suggests that chaperone-mediated insertion is likely
required. Attempts to produce TetA in synthetic liposomes
without the aid of translocons or other membrane-bound com-
ponents were unsuccessful in our cell-free system (data not
shown). Successful synthesis of large membrane proteins like
TetA confirms that insertion and folding in our cell-free system
is effective and can be sustained even over long peptide chains.
TetA incorporation into vesicles is very efficient in our cell-
free system, with over two-thirds of the synthesized protein
being associated with vesicles at the end of the reaction. This
yield does not vary significantly with changes in Ffh, FtsY, or
vesicle concentration (data not shown), likely indicating that
transcription and translation are the rate-limiting steps. MtlA
incorporation, on the other hand, is much less efficient with only
38% of the synthesized protein being associated with vesicles,
thus reflecting a limitation in insertion or folding. Despite the
fact that SRP and FtsY are present at only one-twentieth their
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increase insertion yields. Therefore, the low concentrations
appear to be sufficient for facilitating insertion and folding in
our system. Measured affinities of SRP for ribosome-nascent
chain complexes translating the N-terminal end of leader pep-
tidase have been shown to be sub-nanomolar (0.1 nM, [55]),
indicating that very low concentrations of SRP may be suf-
ficient to facilitate ribosome docking to translocons. Based on
the translation rate and vesicle concentrations in our system, we
estimate that docking of the ribosome-nascent chain complex
takes 0.5–1 s while the total time for translation is 4–6 min [48].
This analysis suggests that 2–8 nM SRP is sufficient to ac-
commodate up to 2 μM of translating ribosomes. This calcu-
lated SRP concentration is comparable to the SRP concentration
we estimate to be present in our system.
Instead, the limitation in MtlA incorporation appears to be
related to the membrane-bound components or the membrane
itself, since variations in vesicle concentration result in cor-
responding changes in inserted yield. Similar dependence on
vesicle concentration has been seen with another E. coli tran-
sporter, aquaporin Z, in our system (Wuu, J.J. and Swartz, J.R.,
unpublished data). Limitations in the membrane-dependent
steps are not unexpected, considering the small amount of
membrane area per reaction volume compared to living cells
(Table 2). One might argue that the dependence on vesicle
concentration is due to a limitation in the amount of membrane
area available for receipt of the expressed protein — in other
words, we have reached the maximum surface density of mem-
brane protein that can be accommodated in the lipid bilayer.
However, given that TetA is able to achieve higher surface
concentrations with the same vesicle concentrations and given
the in vivo observations with inhibited lipid synthesis discussed
earlier [52], it seems unlikely that available membrane area is
limiting MtlA yields. It is more probable that either there are
insufficient translocon concentrations to accommodate the tran-
slating ribosomes or there is insufficient YidC to fold or release
the protein to the lipid environment. To our knowledge, the
effect of YidC depletion is not well characterized for MtlA.
Elucidation of these steps requires further experiments with a
wider range of membrane proteins and with vesicles containing
varying translocon and YidC concentrations.
In this article, we have focused mostly on membrane proteins
that involve the canonical SRP- and translocon-dependent in-
sertion mechanism. However, other insertion mechanisms have
also been elucidated for proteins localized to the inner membrane.
One of the advantages of the strategy we have chosen is that the
components required for these alternative mechanisms are likely
also present in our reactions. For mechanisms that use a subset of
the helper proteins in the canonical insertion pathway – for
example, the YidC pathway [56] and SRP/YidC-dependent,
translocon-independent pathways [57] – all the necessary
components are apparently available in our reaction. In addition,
the Cytomim system is known to activate oxidative phosphoryla-
tion for energy generation which indicates generation of a proton
gradient across vesicle membranes [17]. Therefore, this system
should also be amenable to producing membrane proteins which
require the transmembrane proton gradient, in particular thosewith charged residues flanking the transmembrane regions
[18]. More dissimilar pathways such as the TAT [58] or SecA-
dependent pathways [59] potentially can also be activated be-
cause the required chaperones are expected to be included either
in our E. coli vesicles, if they are membrane-bound, or in our cell
extract, if they are cytoplasmic. Though further work is needed to
verify that these non-canonical pathways do indeed exist in our
reactions, the cell-free platform potentially offers a convenient
approach for studying the specific pathways utilized by any
particular membrane protein. The openness of the reaction en-
vironment allows easy addition and/or removal of components
that may be involved in insertion and folding, as demonstrated by
the supplementation of Ffh and FtsY in this work. Since mem-
brane protein synthesis is sustained over many ribosome turn-
overs, the effects of any changes in the system should be easily
observed.
In summary, we have described a cell-free expression system
that produces folded and active membrane proteins without the
use of detergents or refolding techniques. The yields obtained
for two model proteins, MtlA and TetA, are significantly higher
than corresponding concentrations obtained in vivo. These
model proteins demonstrate that this system can activate natu-
ral folding pathways and successfully produce large complex
membrane proteins containing many transmembrane segments.
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